glp-1/gip agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Upcoming wave of hormone-based therapies

Reejamol MK, Swaminathan M

Whether this finding can be replicated in future studies, and what significance it holds for the broader understanding of GLP-1R agonisms effects on food preference, remains to be determined

Testing and monitoring on an individual basis is key

(PubMed) Johnson JL, Duran M

Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders

Nobiletin showed no obvious cytotoxicity in vivo (0.05% dietary concentration for 320 weeks) or in vitro (effective concentration 40 M), and cells resumed normal growth after withdrawal, with safety superior to existing chemotherapeutic agents (Goh et al., 2019)